Details for Patent: 4,391,802
Summary for Patent: 4,391,802
| Title: | Method of treating leukemia or leukemoid diseases |
| Abstract: | A method of leukemia or leukemoid disease treatment by administration of a vitamin D derivative with a hydroxyl group at 1α-position is disclosed. It is believed that the vitamin D derivative with a hydroxyl group at 1α-position is capable of treating cancer through redifferentiation of cancer cells and that this capability is inherent in vitamin D derivatives with a hydroxyl group at 1α-position. |
| Inventor(s): | Tatsuo Suda, Yoshihei Hirasawa, Sachio Takahashi, Etsuko Abe, Kunio Konno, Tadao Aoki |
| Assignee: | Chugai Pharmaceutical Co Ltd |
| Application Number: | US06/356,385 |
|
Patent Claim Types: see list of patent claims | Use; Dosage form; |
Drugs Protected by US Patent 4,391,802
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 4,391,802
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Japan | 56-35218 | Mar 13, 1981 |
International Family Members for US Patent 4,391,802
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Japan | H0115484 | ⤷ Start Trial | |||
| Japan | S57149224 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
